A row has broken out between EU member states over coronavirus vaccine allocation in the latest fallout from AstraZeneca’s worsening supply shortfalls to the bloc.
欧盟成员国之间就新冠疫苗分配问题发生争执，突显阿斯利康(AstraZeneca)对欧盟供应短缺加剧的最新冲击波。
您已阅读8%（219字），剩余92%（2596字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。